Keywords:Diastereoselective cyclisation / Pyrrolin-1-ium salts / Pyrrolidines / Heterocycles / Synthetic methods A number of new chiral 2-(α-bromoalkyl)pyrrolinium salts and 2-(α-selenoalkyl)pyrrolidines were synthesized by the halocyclisation and selenocyclisation, respectively, of N-(alkenylidene)alkylamines and subsequent reduction. These cyclisations were implemented in a diastereomeric fashion for the first time. Substrate control (starting imines possessing chirality in the N-alkyl or the N-alkenyl substituent) and re-
Diastereoselective Cyclization of N-Alkenylideneamines into 3,4-Dihydro--2H-pyrrol-1-ium Halides. -Novel approaches towards the diastereoselective electrophile-induced cyclization of N-alkenylidene alkylamines are presented. The halocyclization of chiral N-alkenylidene alkylamines (I) proceeds with only low to moderate diastereoselectivity. Similar results are achieved with the selenocyclization of related N-alkenylidene alkylamines (V), and the introduction of additional prochiral substituents into the imines does not give improved stereoselectivities. Diastereoselectivities of up to 68% d.e. are achieved when a chiral imine (XII) is reacted with a chiral selenium bromide (XV) as well as by application of N-alkenylidene alkylamines bearing stereocenters at the alkenylidene chain (XVII). -(SCHLEY, D.; LIEBSCHER*, J.; Eur.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.